Brodsky JB

Language: English
References: 14
Page: 93-96
PDF size: 94.09 Kb.

Text Extraction

Extreme obesity affects every organ system and causes significant chronic medical co-morbidities. Most of the associated conditions are reversible following sustained weight loss. In 1991 the United States’ National Institutes of Health Consensus Development Conference Panel recommended weight reduction (bariatric) surgery for patients with extreme obesity that cannot lose weight by diet and exercise alone. Since then the number of bariatric surgical procedures performed in the United States has risen and currently exceeds 200,000 annually. Most of the information we have on the perioperative management of the morbidly obese patient is based on experience with bariatric operations. This review considers the postoperative management of the morbidly obese patient. Most obese patients recover from anesthesia and surgery in the PACU. Admission to an intensive care unit is usually due to either severe underlying medical conditions, and/or complex surgical procedures.

REFERENCES

1. Helling TS, et al. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery. Obes Surg 2004;14:1036-41.

2. McCarty TM, et al. Optimizing outcomes in bariatric surgery. Outpatient laparoscopic gastric bypass. Ann Surg 2005;242: 494-501.

3. Eichenberger A, et al. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg 2002;95:1788-92.

4. Collins JS, et al. Laryngoscopy and morbid obesity: a comparison of the “sniff” and “ramped” positions. Obes Surg 2004;14:1171-5.

5. Keller C, et al. The Laryngeal Mask Airway ProSeal (TM) as a temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation. Anesth Analg 2002;94:737- 40.

6. Huerta S, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002; 6:354-8.

7. Gaszynski T, et al. Boussignac CPAP in the postoperative period in morbidly obese patients. Obes Surg 2007;17:452-6.

8. Eriksson S, et al. The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg 1997;7:332-5.

9. Rawal N, et al. Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese: influence on postoperative ambulation and pulmonary function. Anesth Analg 1984;63:583-92.

10. Feld JM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth 2006;18:24-8.

11. de Menezes Ettinger JE, et al. Prevention of rhabdomyolysis in bariatric surgery. Obes Surg 2005;15:874-9.

12. Meijer AR, et al. Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey. Intensive Care Med 2003;29:1121-5.

13. Faintuch J, et al. Rhabdomyolysis after gastric bypass: severity and outcome patterns. Obes Surg 2006;16:1209-13.

14. Lagandre S, et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obes Surg 2006;16:1365-70.